These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12808383)

  • 1. Insulin sensitizers for polycystic ovary syndrome.
    Baillargeon JP; Iuorno MJ; Nestler JE
    Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
    [No Abstract]   [Full Text] [Related]  

  • 2. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
    Iuorno MJ; Nestler JE
    Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.
    Diamanti-Kandarakis E; Zapanti E
    Ann N Y Acad Sci; 2000; 900():203-12. PubMed ID: 10818407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-sensitising agents in polycystic-ovary syndrome.
    Sattar N; Hopkinson ZE; Greer IA
    Lancet; 1998 Jan; 351(9099):305-7. PubMed ID: 9652605
    [No Abstract]   [Full Text] [Related]  

  • 5. Troglitazone use in polycystic ovary syndrome.
    Landman RE; Jacobs TP
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5090-1. PubMed ID: 11600596
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
    Blonde L; Sandberg MI; Guthrie RD
    Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Troglitazone for treatment of polycystic ovary syndrome].
    Sanaka M; Iwamoto Y
    Nihon Rinsho; 2000 Feb; 58(2):465-70. PubMed ID: 10707578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
    Pugeat M
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S25-9. PubMed ID: 12773915
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
    van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB
    Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL; Fugate SE
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
    Dunaif A; Scott D; Finegood D; Quintana B; Whitcomb R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3299-306. PubMed ID: 8784087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.
    Bloomgarden ZT; Futterweit W; Poretsky L
    Endocr Pract; 2001; 7(4):279-86. PubMed ID: 11497481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.
    Hasegawa I; Murakawa H; Suzuki M; Yamamoto Y; Kurabayashi T; Tanaka K
    Fertil Steril; 1999 Feb; 71(2):323-7. PubMed ID: 9988406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin concentrations in the polycystic ovary syndrome.
    Mantzoros CS; Dunaif A; Flier JS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1687-91. PubMed ID: 9177364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H; Paudel KR; Sharma M
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 20. Troglitazone-induced pulmonary edema.
    Inoue K; Sano H
    Arch Intern Med; 2000 Mar; 160(6):871-2. PubMed ID: 10737290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.